UPDATED Mar 29, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$420.72 | -1.9% | 45.9% | US$3.1t | US$468.20 | PE37.9x | E12.6% | 0.7% | Software | ||
GOOGL | US$150.93 | 0.1% | 45.5% | US$1.9t | US$164.92 | PE25.4x | E11.8% | n/a | Media | ||
META | US$485.58 | -4.7% | 129.1% | US$1.2t | US$524.03 | PE31.7x | E14.3% | 0.4% | Media | ||
ADBE | US$504.60 | 1.0% | 30.9% | US$226.1b | US$617.38 | PE47.1x | E17.1% | n/a | Software | ||
NOVN | CHF87.37 | 1.0% | 4.3% | CHF191.3b | CHF97.29 | PE24.8x | E9.4% | 3.8% | Pharmaceuticals & Biotech | ||
ROG | CHF229.70 | 2.0% | -12.0% | CHF184.5b | CHF280.47 | PE15.9x | E8.3% | 4.2% | Pharmaceuticals & Biotech | ||
AXP | US$227.69 | 0.8% | 38.0% | US$163.9b | US$208.71 | PE19.9x | E8.9% | 1.2% | Diversified Financials | ||
PDD | US$116.25 | -5.5% | 53.2% | US$154.4b | US$180.23 | PE18.6x | E23.0% | n/a | Retail | ||
AIR | €170.72 | 0.5% | 38.5% | €134.4b | €172.40 | PE35.5x | E17.6% | 1.1% | Capital Goods | ||
VRTX | US$418.01 | 0.6% | 32.7% | US$108.0b | US$459.71 | PE29.8x | E11.2% | n/a | Pharmaceuticals & Biotech | ||
SAF | €210.05 | 1.4% | 53.8% | €86.9b | €200.21 | PE25.2x | E5.2% | 1.0% | Capital Goods | ||
CSL | AU$287.92 | 2.5% | -0.1% | AU$139.1b | AU$303.47 | PE36.7x | E15.2% | 1.3% | Pharmaceuticals & Biotech | ||
SLB | US$54.81 | 1.5% | 11.6% | US$78.5b | US$67.36 | PE18.7x | E12.3% | 2.0% | Energy | ||
CRWD | US$320.59 | -2.1% | 133.6% | US$77.5b | US$390.31 | PE868.1x | E34.7% | n/a | Software | ||
1299 | HK$52.55 | -6.1% | -36.4% | HK$588.6b | HK$96.82 | PE20x | E17.5% | 3.1% | Insurance | ||
NTES | US$103.47 | -1.9% | 17.0% | US$64.7b | US$135.66 | PE15.9x | E8.1% | 2.5% | Media | ||
4568 | JP¥4,777.00 | -2.8% | -0.9% | JP¥9.2t | JP¥5,620.00 | PE49.2x | E23.9% | 1.3% | Pharmaceuticals & Biotech | ||
2454 | NT$1,195.00 | 6.2% | 51.8% | NT$1.9t | NT$1,190.76 | PE24.7x | E13.4% | 5.1% | Semiconductors | ||
600809 | CN¥245.08 | -0.7% | -10.0% | CN¥299.0b | CN¥289.47 | PE28.7x | E16.7% | 1.4% | Food, Beverage & Tobacco | ||
ALC | CHF74.74 | -0.2% | 15.5% | CHF36.9b | CHF84.21 | PE42x | E10.7% | 0.3% | Healthcare | ||
G | €23.46 | 1.1% | 27.6% | €37.0b | €22.80 | PE10.1x | E5.6% | 5.5% | Insurance | ||
2020 | HK$83.20 | 4.7% | -27.0% | HK$235.7b | HK$111.08 | PE21.3x | E13.1% | 2.8% | Consumer Durables | ||
RMD | US$198.03 | 3.1% | -9.6% | US$29.1b | US$204.98 | PE32.7x | E13.6% | 1.0% | Healthcare | ||
HWM | US$68.43 | 0.5% | 61.5% | US$28.1b | US$68.97 | PE36.8x | E14.5% | 0.3% | Capital Goods |